Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Valentine Barboux

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Statistics in Medicine|December 15, 2018
Predictive probability of success using surrogate endpointsGaelle Saint-Hilary, Valentine Barboux, Matthieu Pannaux, et al.
Statistics in Medicine|January 23, 2026
Dual-Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time-to-Event Group Sequential TrialsMarco Ratta, Gaëlle Saint-Hilary, Valentine Barboux, et al.
Clinical Colorectal Cancer|January 16, 2025
Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT TrialJulien Taieb, Marwan Fakih, Josep Tabernero, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2025
Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trialJulien Taieb, Dominik P Modest, Marwan Fakih, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Statistics in Medicine|December 15, 2018
Predictive probability of success using surrogate endpointsGaelle Saint-Hilary, Valentine Barboux, Matthieu Pannaux, et al.
Statistics in Medicine|January 23, 2026
Dual-Criterion Approach Incorporating Historical Information to Seek Accelerated Approval With Application in Time-to-Event Group Sequential TrialsMarco Ratta, Gaëlle Saint-Hilary, Valentine Barboux, et al.
Clinical Colorectal Cancer|January 16, 2025
Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT TrialJulien Taieb, Marwan Fakih, Josep Tabernero, et al.
European Journal of Cancer (Oxford, England : 1990)|July 22, 2025
Impact of trifluridine/tipiracil plus bevacizumab on tumor shrinkage and depth of response in refractory metastatic colorectal cancer: analysis of the SUNLIGHT trialJulien Taieb, Dominik P Modest, Marwan Fakih, et al.
Pageof 1